EMAIL THIS PAGE TO A FRIEND

American journal of physiology. Gastrointestinal and liver physiology

L-Ornithine phenylacetate reduces ammonia in pigs with acute liver failure through phenylacetylglycine formation: a novel ammonia-lowering pathway.


PMID 25258408

Abstract

Glycine is an important ammoniagenic amino acid, which is increased in acute liver failure (ALF). We have previously shown that L-ornithine phenylacetate (OP) attenuates ammonia rise and intracranial pressure in pigs suffering from ALF but failed to demonstrate a stoichiometric relationship between change in plasma ammonia levels and excretion of phenylacetylglutamine in urine. The aim was to investigate the impact of OP treatment on the phenylacetylglycine pathway as an alternative and additional ammonia-lowering pathway. A well-validated and -characterized large porcine model of ALF (portacaval anastomosis, followed by hepatic artery ligation), which recapitulates the cardinal features of human ALF, was used. Twenty-four female pigs were randomized into three groups: (1) sham operated + vehicle, (2) ALF + vehicle, and (3) ALF + OP. There was a significant increase in arterial glycine concentration in ALF (P < 0.001 compared with sham), with a three-fold increase in glycine release into the systemic circulation from the kidney compared with the sham group. This increase was attenuated in both the blood and brain of the OP-treated animals (P < 0.001 and P < 0.05, respectively), and the attenuation was associated with renal removal of glycine through excretion of the conjugation product phenylacetylglycine in urine (ALF + vehicle: 1,060 ± 106 μmol/l; ALF + OP: 27,625 ± 2,670 μmol/l; P < 0.003). Data from this study provide solid evidence for the existence of a novel, additional pathway for ammonia removal in ALF, involving glycine production and removal, which is targeted by OP.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A0325000
Alanine, European Pharmacopoeia (EP) Reference Standard
C3H7NO2
368407
Deuterium, 99.96 atom % D
D2
617474
Deuterium, 99.9 atom % D
D2
361860
Deuterium, 99.8 atom % D
D2
488690
Deuterium hydride, extent of labeling: 96 mol% DH, 98 atom % D
HD
58958
Ethyl acetate, analytical standard
C4H8O2
17023
Ethyl acetate, tested according to Ph.Eur.
C4H8O2
PHR1481
Ethyl Acetate, Pharmaceutical Secondary Standard; Certified Reference Material
C4H8O2
76524
Glycine, certified reference material, TraceCERT®
C2H5NO2
50058
Glycine, tested according to Ph.Eur.
C2H5NO2
PHR1111
Glycine, Pharmaceutical Secondary Standard; Certified Reference Material
C2H5NO2
1295800
Glycine, United States Pharmacopeia (USP) Reference Standard
C2H5NO2
94119
Glycine, analytical standard, for nitrogen determination according to Kjeldahl method
C2H5NO2
G0450000
Glycine, European Pharmacopoeia (EP) Reference Standard
C2H5NO2
112003
Hippuric acid, 98%
C9H9NO3
S0450000
Serine, European Pharmacopoeia (EP) Reference Standard
C3H7NO3
306975
tert-Butyl methyl ether, anhydrous, 99.8%
C5H12O
675407
tert-Butyl methyl ether, HPLC Plus, for HPLC, GC, and residue analysis, 99.9%
C5H12O
08603
tert-Butyl methyl ether, analytical standard
C5H12O
293210
tert-Butyl methyl ether, HPLC grade, for HPLC, 99.8%
C5H12O
PHR1560
tert-Butyl Methyl Ether, Pharmaceutical Secondary Standard; Certified Reference Material
C5H12O